Bariatric & obesity medicine prior authorization at Humana
PA workflow, documentation criteria, and peer-to-peer prep — for prescribers and PA staff
Humana bariatric & obesity medicine PA at a glance
Humana reviews bariatric & obesity medicine PA submissions against its medical policy library, with rules drawn primarily from AACE / ACE Obesity Management Algorithm + Obesity Society Position Statements. Humana-specific context: Heavily Medicare Advantage focused. MA-specific appeal track (42 CFR Part 422 Subpart M) applies — 60 days to request reconsideration, NOT the 180 days for commercial plans. Auto-forward to IRE (Maximus) if Humana misses deadline.
Documentation packet — what to send
- BMI with date of measurement
- Comorbidity documentation (T2D, HTN, OSA, dyslipidemia, NAFLD)
- Lifestyle / behavioural intervention attempt (program + duration)
- Prior anti-obesity medication trials
- Pregnancy / breastfeeding status
Common denial patterns to pre-empt
Patterns observed in bariatric & obesity medicine across payers, and where Humana's book of business overlaps:
- Weight-loss exclusion in plan benefit (employer carve-out)
- BMI threshold above FDA label
- Comorbidity documentation (HTN, OSA, dyslipidemia) missing
- Step therapy through cheaper AOM first
- Lifestyle program participation not documented
- MA plan step therapy on Part B drugs
Appeal angles when Humana denies
- FDA label match (BMI ≥30, or BMI ≥27 with comorbidity)
- SURMOUNT / STEP trial citation
- Sleep study confirming OSA as comorbidity
- Documented prior lifestyle intervention with weight + duration
Peer-to-peer prep
- Quote the SURMOUNT-1 / SURMOUNT-3 / STEP trial results by name
- Document the lifestyle program with name and duration (e.g. Noom 6 months, in-person dietitian)
- Differentiate the diabetes vs obesity indication for semaglutide / tirzepatide explicitly
- Quote AACE Obesity Algorithm if the case is borderline
Drug-specific PA criteria at Humana
Deep dives on each drug's PA criteria at Humana:
Frequently asked questions
What documentation does Humana need for bariatric & obesity medicine prior authorizations?
Humana's PA packet for bariatric & obesity medicine typically includes: BMI with date of measurement; Comorbidity documentation (T2D, HTN, OSA, dyslipidemia, NAFLD); Lifestyle / behavioural intervention attempt (program + duration); Prior anti-obesity medication trials. AACE / ACE Obesity Management Algorithm + Obesity Society Position Statements citations strengthen the submission.
What's the turnaround at Humana?
Humana standard decision: 30 days. Expedited (urgent care): 72 hours per 45 CFR §147.136. Medicare Advantage extension rule under 42 CFR Part 422 may add 14 days. Internal appeal window if denied: 60 days.
Which bariatric & obesity medicine drugs does Humana most often PA-restrict?
Top targets in bariatric & obesity medicine: semaglutide, tirzepatide, liraglutide. Each follows the per-drug step therapy + documentation requirements published in Humana's medical policy library.
How do I prep a peer-to-peer with Humana in bariatric & obesity medicine?
Quote the SURMOUNT-1 / SURMOUNT-3 / STEP trial results by name Document the lifestyle program with name and duration (e.g. Noom 6 months, in-person dietitian) Have the policy URL and the patient's chart open before the call.
Generate a Bariatric & obesity medicine PA packet
Open ApprovalHelp — generate a bariatric & obesity medicine PA packet tailored to Humana's criteria, with prescriber attestation and supporting citations pre-filled.
Get started →Contact: hello@approvalhelp.com